Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Care of older people

Long-term diuretic use may reduce fracture risk in people with Alzheimer’s disease

Using data from 10,416 community-dwelling people with Alzheimer’s disease, researchers found that thiazide use was associated with a 17% reduced odds of low-energy fracture compared with non use.

Use of thiazide diuretics for three years or more may reduce the risk of low-energy fracture (LEF) in people with Alzheimer’s disease (AD), study results published in Osteoporosis International have suggested (16 April 2019)[1].

The researchers used data from a national Finnish database on 10,416 community-dwelling people with AD who experienced LEF and 5,578 with hip fracture, matched to up with three controls without fracture.

Current thiazide use was associated with a 17% reduced odds of LEF compared with non use. There was no association between LEF and short-term use of thiazides. However, use for three years or more was associated with a 23% reduced odds of LEF and a 32% reduced odds of hip fracture.

LEF is usually associated with falls — of which people with AD are at increased risk — which the researchers said made the results “somewhat surprising”. But they suggested that thiazides could affect fracture risk by reducing calcium excretion, leading to increased bone mineral density.

“This finding may have implications for the choice of antihypertensive medications in this vulnerable patient group with an increased background risk for falls and fractures due to dementia disorder,” they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206526

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Non-medical Prescribing

    Non-medical Prescribing

    An essential new guide designed to ensure confident prescribing in specialist areas.

    £27.00Buy now
  • Non-prescription Medicines

    Non-prescription Medicines

    Reviews over-the-counter medicines, arranged by the conditions they are licensed to treat. Includes product recommendations.

    £38.00Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.